Social cognition, mental health and quality of life in people with MS

Professor Julie Henry

University of Queensland

| Better treatments | Social And Applied Research | Incubator | 2019 | Investigator Led Research |
SUPPORT PROJECTS WITH THIS RESEARCH FOCUS

Summary

Social cognition refers to the processing of social information, such as the ability to recognise facial emotions. The impact of social cognitive impairment has been overlooked in various neurological disorders. This has recently changed with it being recognised as one of the six core components of cognitive function. Impairment in social cognition may be evident in the early stages of MS and may provide information on the longer term outcomes of social functioning and quality of life. Therefore, screening for such impairments is crucial for improving the quality of life of people with MS. At this stage, social cognitive function still isn’t routinely looked at in the clinic.

Currently, it is still not known which measurements for social cognitive impairment are best suited for people with MS and which can predict the longer-term outcomes, such as mental health and wellbeing. This research project aims to address these issues by comparing conventional tests with more true-to-life social cognitive tests and looking at how well these tests predict real-world outcomes. Professor Henry will also look at cognitive (e.g. attention, memory, learning) and lifestyle (e.g. exercise, diet, living conditions) factors and the role they play in social cognitive impairment.

By identifying sensitive tests to assess impairments in social cognition, the findings of this research will have direct implications for clinical practice, where advancements will be made in the understanding, treatment and management of MS.

Progress to Date

Although recruitment for this project has been delayed due to the COVID-19 pandemic, Professor Henry has already recruited and assessed more than half of the participants required for this study. This includes 25 people with MS and 25 people without MS who will act as controls for the study. The participants all underwent 2-3 hours of extensive cognitive testing;  including facial recognition tests, the ability to recognise emotions in others, as well as more general cognition testing to look at attention levels, language, learning and memory ability.

The researchers report that now the pandemic restrictions have eased, the study is progressing well, and they are very hopeful that they will be able to completely finalise the study by the end of 2021.

Updated 1 April 2021

Updated: 02 January, 2019

Stages of the research process

Fundamental laboratory
Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline: 10+ years
Translational
Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline: 5+ years
Clinical Studies
and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline: 1-5 years

Investigator

  • Professor Julie Henry

Co-investigator

  • Dr Stefan Blum
  • Dr Sarah Grainger
  • Dr Daniel Schweitzer

Grant Awarded

  • Incubator Grant

Total Funding

  • $24,557

Duration

  • 2 years

Funding Partner

  • Neil and Norma Hill Foundation
Read More

Newsletter subscription

  • Enter your details

Social cognition, mental health and quality of life in people with MS